| 000 | 03315nam a22003495i 4500 | ||
|---|---|---|---|
| 999 |
_c81181 _d81181 _x1 |
||
| 001 | 81181 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040318.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 150320s2015 xxu| s |||| 0|eng d | ||
| 020 | _a9781493921904 | ||
| 024 | 7 |
_a10.1007/978-1-4939-2190-4 _2doi |
|
| 040 | _dES-MaUEC | ||
| 050 | 4 |
_aRC553.A88 _bT446 2015 |
|
| 245 | 1 | 4 |
_aThe Molecular Basis of Autism _cedited by S. Hossein Fatemi. |
| 260 |
_aNew York _bSpringer International Publishing _c2015 |
||
| 300 |
_a1 recurso en línea (XVIII, 437 p.) _b38 ilustraciones, 17 ilustraciones en color |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 | _aContemporary Clinical Neuroscience | |
| 505 | 0 | _aPreface -- A Brief History of Autism -- Autism Spectrum Disorder: Diagnostic Considerations -- Epidemiologic Features of Autism Spectrum Disorders -- Genetics of Autism Spectrum Disorders: The Opportunity and Challenge in the Genetics Clinic -- Epigenetic Regulation in Autism -- Immunology of Autism -- Neuroimaging in Autism Spectrum Disorders -- The Neuropathology of Autism -- Pharmacology of ASD Spectrum Disorder -- Behavioral Therapies -- Autism and Dopamine -- Autism and Glutamate -- Serotonin in Autism Spectrum Disorder: Insights From Human Studies and Animal Models -- Oxytocin and Vasopressin in Autism and Genetic Syndromes -- Molecular basis of cholinergic changes in autistic spectrum disorders and relevance for treatment interventions -- Reelin, GABA, FMRP, and Autism -- The Role of Neurexins and Neuroligins in Autism -- Neurotrophins, their receptors and autism: ligand vs. receptor abnormalities -- Cognition, Motor Control and Other Aspects of Autism: A Pragmatic Review -- Increased vulnerability to oxidative stress and mitochondrial dysfunction in autism -- Index. | |
| 520 | _aThis book is a comprehensive overview of the clinical and scientific aspects of Autism from the leading experts in the field. The clinical section covers everything from epidemiological features to epigenetic regulation to behavioral therapies and much in between. The basic science section presents the latest knowledge on the underlying causes of the disorder including the role of various neurotransmitters, neurexins and neuroligins, reelin, and other proteins. Chapters also explore the cognition and motor control in autism and the connection between oxidative stress and mitochondrial dysfunction and autism. The thorough description of these underlying causes may help researchers and clinicians find more effective treatments and therapies for the 1 in 68 American children who have been diagnosed with Autism. | ||
| 650 | 7 |
_2embne _aAutismo _9141122 |
|
| 700 | 1 |
_aFatemi, S. Hossein _eeditor literario _980545 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4939-2190-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b12897711 _b10-10-17 _c18-01-16 |
||
| 942 |
_2lcc _cLE |
||
| 945 |
_aRC553.A88 T446 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11567338 _z06-04-17 |
||
| 988 | _aEBSPRINGER | ||
| 998 |
_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gxxu _h4 |
||